Homebuilders Seeing Upside as Goldman Adds DR Horton to Buy List (DHI, TOL, LEN, more..)

Homebuilders are rallying today on the back of Goldman Sachs adding DR Horton (NYSE: DHI) to its Conviction Buy list. The SPDR S&P Homebuilders ETF (AMEX: XHB) is currently trading nearly 2% higher as Goldman is becoming more optimistic about earnings among the homebuilders.

Here are some popular homebuilders and their performance for today:

• DR Horton (NYSE: DHI) up 3%
  
• Toll Brothers (NYSE: TOL) up 1%
  
• KB Home (NYSE: KBH) up 1.3%
  
• Lennar (NYSE: LEN) up 4.4%
  
• Centex (NYSE: CTX) up 4.5%
  
• Hovnanian (NYSE: HOV) up 3%

D.R. Horton, Inc. operates as a homebuilding company in the United States.

You May Also Be Interested In

• Lowe's (LOW) PT Lowered to $275 at Guggenheim
• Goldman Sachs Downgrades Shanghai Jahwa United (600315:CH) to Neutral
• NetEase.com (NTES) PT Raised to $168 at Goldman Sachs